Serum 1,5-Anhydroglucitol: Risk Factor of Acute Ischemic Stroke and Transient Ischemic Attack in Well-Controlled Diabetes.

MLA

Shiga, Yuji, et al. “Serum 1,5-Anhydroglucitol: Risk Factor of Acute Ischemic Stroke and Transient Ischemic Attack in Well-Controlled Diabetes.” Cerebrovascular Diseases, vol. 44, no. 5/6, Dec. 2017, pp. 325–29. EBSCOhost, https://doi.org/10.1159/000481626.

APA

Shiga, Y., Kuriyama, M., Kanaya, Y., Takeshima, S., Takemaru, M., Takamatsu, K., Shimoe, Y., Fujikawa, Y., & Nishigaki, M. (2017). Serum 1,5-Anhydroglucitol: Risk Factor of Acute Ischemic Stroke and Transient Ischemic Attack in Well-Controlled Diabetes. Cerebrovascular Diseases, 44(5/6), 325–329. https://doi.org/10.1159/000481626

Chicago

Shiga, Yuji, Masaru Kuriyama, Yuhei Kanaya, Shinichi Takeshima, Makoto Takemaru, Kazuhiro Takamatsu, Yutaka Shimoe, Yasunori Fujikawa, and Masakazu Nishigaki. 2017. “Serum 1,5-Anhydroglucitol: Risk Factor of Acute Ischemic Stroke and Transient Ischemic Attack in Well-Controlled Diabetes.” Cerebrovascular Diseases 44 (5/6): 325–29. doi:10.1159/000481626.